Also trades as: KTYCF (OTC) · $vol 0M
KITS.TO TSX
Kits Eyecare Ltd.
1W: +0.4%
1M: +0.2%
3M: +10.3%
YTD: -20.6%
1Y: -4.2%
3Y: +197.6%
5Y: +379.5%
C$16.20 ($11.34)
+0.56 (+3.58%)
Weekly Expected Move ±3.3%
C$15
C$15
C$16
C$16
C$17
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$202M
+27.1% ▲
5Y CAGR: +21.9%
Gross Profit
$71M
+32.9% ▲
5Y CAGR: +27.2%
Operating Income
$8M
+52.3% ▲
5Y CAGR: +132.4%
Net Income
$3M
-0.2% ▼
EPS (Diluted)
$0.09
-0.8% ▼
EBITDA
$11M
+28.1% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $82M | $92M | $121M | $159M | $202M |
| YoY Growth | +9.6% | +11.2% | +31.5% | +32.2% | +27.1% |
| Cost of Revenue | $62M | $62M | $80M | $106M | $131M |
| Gross Profit | $21M | $29M | $41M | $54M | $71M |
| Gross Margin | 25.4% | 31.9% | 33.8% | 33.7% | 35.2% |
| R&D Expenses | $817K | $681K | $817K | $0 | $0 |
| SG&A Expenses | $36M | $34M | $25M | $32M | $63M |
| Operating Expenses | $38M | $34M | $43M | $48M | $63M |
| Operating Income | -$17M | -$4M | -$2M | $5M | $8M |
| Operating Margin | -20.7% | -4.7% | -2.0% | 3.4% | 4.1% |
| Interest Expense | $2M | $2M | $2M | $2M | $680K |
| Income Before Tax | -$19M | -$6M | -$3M | $4M | $5M |
| Tax Expense | -$4M | -$1M | -$676K | $1M | $2M |
| Net Income | -$15M | -$5M | -$2M | $3M | $3M |
| Net Margin | -17.7% | -5.0% | -1.8% | 2.0% | 1.5% |
| EPS (Diluted) | $-0.47 | $-0.15 | $-0.07 | $0.09 | $0.09 |
| EBITDA | -$14M | -$721K | $2M | $8M | $11M |
| Shares Outstanding | 31M | 31M | 31M | 34M | 34M |